Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982535priorityCriticalpatent/ECSP982535A/en
Publication of ECSP982535ApublicationCriticalpatent/ECSP982535A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Un método para el tratamiento y/o la profilaxia de diabetes mellitus, condiciones asociadas con la diabetes mellitus y ciertas complicaciones de la misma, en un mamífero, cuyo método comprende administrar una cantidad eficaz no tóxica y farmacéuticamente aceptables de un sensibilizador a insulina y un agente antihiperglucémico del tipo de biguanida, a un mamífero que necesita de ello, y a una composición farmacéutica que comprende un sensibilizador a insulina y un agente antihiperglucémico del tipo de biguanida.A method for the treatment and / or prophylaxis of diabetes mellitus, conditions associated with diabetes mellitus, and certain complications thereof, in a mammal, the method of which comprises administering a non-toxic and pharmaceutically acceptable effective amount of an insulin sensitizer and a biguanide-type antihyperglycemic agent, a mammal in need thereof, and a pharmaceutical composition comprising an insulin sensitizer and a biguanide-like antihyperglycemic agent.
ECSP9825351998-06-161998-06-16
NEW TREATMENT METHOD (I)
ECSP982535A
(en)
USE OF AN INSULIN SENSITIZER AND AN ANTI-HYPERGLYCEMIC AGENT FOR THE PREPARATION OF MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS.
USE OF AN INSULIN SENSITIZER AND AN ANTIHIPERGLUCEMIC AGENT FOR THE PREPARATION OF A PHARMACEUTICAL MEDICINAL AND COMPOSITION THAT UNDERSTANDS SENSITIZER AND SUCH AGENT
ORAL DOSAGE FORM INCLUDING 5- [4- [2- (N-METHYL-N- (2- PIRIDIL) -AMINO) -ETOXI] -BENCIL] -TIAZOLIDINO-2,4-DIONA AND ANOTHER ADDITIONAL ANTI-DIABETIC AGENT; PROCEDURE FOR THE PREPARATION AND USE OF 5- [4- [2- (METIL-N- (2-PIRIDIL) -AMINO) -ETOXI] - BENCIL] - TIAZOLIDINO-2,4-DIONA AND ANOTHER ANTIDIABETIC AGENT
PHARMACEUTICAL CONTAINER OF USE FOR THE TREATMENT AND PREVENTION OF INFECTIONS BY THE VIRUS OF HEPATITIS B, PROCEDURE FOR THE TREATMENT OF PATIENTS OR PATIENTS SUSCEPTIBLE IN SUFFERING INFECTIONS BY THE VIRUS OF HEPATITIS B.
THE USE OF A LEPTINE SENSITIZER OR A PHARMACEUTICALLY ACCEPTABLE DERIVATIVE OF IT FOR THE MANUFACTURING OF A MEDICATION USEFUL FOR THE TREATMENT AND / OR PROPHYLAXIS OF LEPTIN RESISTANCE AND / OR STATES ASSOCIATED WITH LEPTIN RESISTANCE AND / OR